Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

The biosensors market is being driven by a significant increase in chronic illnesses such as diabetes, a surge in research and development for biotechnology, and the surge in demand for homecare ...

A multidisciplinary research team at the Wyss Institute at Harvard University has developed a new coating technology that holds promise to substantially increase the lifespan of implanted and wearable ...

Medical sensors improve the accuracy of disease detection and treatment planning by enabling accurate diagnostics and ...

With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

Understand the significant growth trajectory of the Implantable Devices segment, which is expected to reach US$2.8 Billion by 2030 with a CAGR of a 6.5%. The Wound Care segment is also set to grow at ...

Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.

Scientists have created a handheld sensor that can quickly detect bird flu (H5N1) in the air, potentially stopping ...